Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss

v2.4.0.8
Condensed Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Operating expenses:        
Research and development $ 3,848 $ 703 $ 10,546 $ 3,162
General and administrative 1,687 683 5,853 2,780
Total operating expenses 5,535 1,386 16,399 5,942
Loss from operations (5,535) (1,386) (16,399) (5,942)
Other (expense) income:        
Interest income 19   48 1
Interest expense (191) (219) (565) (640)
Other (expense) income, net (254) 298 (2,279) 422
Net loss (5,961) (1,307) (19,195) (6,159)
Net (loss) income attributable to common stockholders (5,961) 42,870 (19,195) 16,478
Net loss (5,961) (1,307) (19,195) (6,159)
Other comprehensive loss:        
Unrealized loss on marketable securities (15)   (17)  
Other comprehensive loss (15)   (17)  
Comprehensive loss $ (5,976) $ (1,307) $ (19,212) $ (6,159)
Basic net (loss) income per common share $ (0.44) $ 422.95 $ (1.72) $ 433.33
Diluted net loss per common share $ (0.44) $ (1.79) $ (1.72) $ (8.94)
Weighted average common shares outstanding used to calculate basic net loss per common share 13,468,081 101,358 11,148,695 38,027
Weighted average common shares outstanding used to calculate diluted net loss per common share 13,468,081 731,970 11,148,695 688,825